Core Viewpoint - The 2025 Medtec China exhibition will focus on medical-grade materials, high-precision components, and manufacturing technologies, showcasing over 470 new products and attracting more than 85,000 industry professionals [1][5][39]. Industry Overview - The medical device industry in China reached a market size of 1.18 trillion yuan in 2023, with a circulation market size of 1.36 trillion yuan, reflecting a year-on-year growth of 6.25%. The revenue of production enterprises is expected to reach 1.35 trillion yuan in 2024, maintaining China's position as the second-largest single-country market globally [6]. - From 2018 to 2024, 608 innovative medical devices were approved, with domestic products accounting for 91.45% (556 items). The growth rate for 2024 is projected at 24.83% [6]. Exhibition Details - The exhibition will take place from September 24 to 26, 2025, at the Shanghai World Expo Exhibition and Convention Center, featuring over 1,000 suppliers and brands across 17 categories [1][39]. - The event will include a "Manufacturing Festival" area at the entrance, showcasing innovative products from the supply chain [20]. Product Categories - The exhibition will cover various product categories, including medical device components, innovative materials, electronic components, medical tubing, and manufacturing equipment, with over 470 new products launched annually [5][8]. Networking and Events - A special lunch event for major buyers will be held on September 24-25, aimed at facilitating discussions between exhibitors and attendees with clear procurement needs [26]. - An innovation medical device R&D closed-door meeting will take place on September 25, inviting companies and universities involved in innovative medical device development to share breakthroughs [27]. Trends and Innovations - Key trends include the integration of AI in medical devices, advancements in 4D bioprinting for regenerative medicine, and the development of smart dressings for wound management, which can reduce treatment costs by 60% and shorten healing times [36][37]. - The exhibition will also address regulatory compliance and the impact of new FDA regulations on AI medical devices [36].

Core Viewpoint - The 2025 Medtec International Medical Device Design and Manufacturing Exhibition will focus on high-quality raw materials, precision components, and manufacturing technologies, taking place from September 24-26, 2025, at the Shanghai World Expo Exhibition and Convention Center [2][44]. Industry Overview - The medical device industry in China reached a market size of 1.18 trillion yuan in 2023, with a circulation market size of 1.36 trillion yuan, reflecting a year-on-year growth of 6.25%. The revenue of manufacturing enterprises is expected to reach 1.35 trillion yuan in 2024, maintaining its position as the second-largest single-country market globally [5]. - From 2018 to 2024, a total of 608 innovative medical devices were approved, with domestic products accounting for 91.45% (556 items). The growth rate for 2024 is projected at 24.83% [5]. Exhibition Highlights - The exhibition will showcase over 470 new products, including medical device components, innovative materials, electronic components, medical tubing, and extrusion products, as well as manufacturing equipment [4][8]. - The event will feature more than 1,000 global suppliers and brands across 17 categories, emphasizing a comprehensive approach to medical device design and manufacturing [7]. Innovation and Technology - Key areas of innovation include AI medical software, brain-machine interfaces, and exoskeleton robots, with a focus on advanced technologies such as AI pathology diagnosis systems and laparoscopic surgical robots [5]. - The exhibition will also introduce a "Manufacturing Festival" to highlight innovative products from the supply chain, allowing attendees to quickly locate exhibitors and learn about new offerings [19]. Networking and Collaboration - The event will host specialized networking opportunities, including a lunch meeting for major buyers with clear procurement needs, aimed at facilitating valuable discussions between exhibitors and attendees [27]. - A closed-door meeting on innovative medical device R&D will take place, inviting companies and universities to share breakthrough products and technologies [29]. Regulatory and Market Trends - The exhibition will address regulatory challenges, such as the FDA's new requirements for continuous clinical monitoring of AI medical devices, emphasizing the need for real-time risk warning systems to avoid post-market recalls [39]. - The event will also explore emerging markets, such as the weight management sector, which is projected to grow significantly under national initiatives [40].

Summary of Kangji Medical Conference Call Industry Overview - The global minimally invasive surgical consumables market is projected to reach approximately $32 billion by 2024, with a compound annual growth rate (CAGR) of only 5% due to aging populations in Europe and the US, as well as open-chest surgeries in underdeveloped regions [2][4] - The Chinese market is expected to grow significantly, with a projected CAGR of 12%, reaching approximately 26 billion yuan in 2024 and 40.7 billion yuan by 2028 [2][5] - The number of minimally invasive surgeries in China is anticipated to increase from 14 million in 2023 to 24 million by 2028, with a slight increase in the average price of consumables [2][6] Company Insights - Kangji Medical's market share has increased significantly from 2-3% in 2019 to around 14% in 2023, benefiting from accelerated domestic substitution as international giants like Medtronic exit certain product lines due to cost pressures [2][8] - The company leads in disposable puncture devices, polymer ligation clips, and electrocautery forceps, while actively expanding into ultrasonic knives, staplers, and sutures [2][3] - Kangji Medical is also developing products in the laparoscopic robotic field, with its first laparoscopic surgical robot expected to drive growth in surgical robot consumables [3] Financial Performance - Kangji Medical's revenue for 2024 is projected to be around 1 billion yuan, with profits nearing 600 million yuan [4][16] - The company maintains a strong cash flow, with approximately 1.4 billion yuan in cash by the end of 2024 and a commitment to a high dividend payout ratio of 60-80% [4][22] - The overall compound growth rate for Kangji Medical is expected to be between 16-17% over the next three years, with new products like ultrasonic knives and staplers potentially achieving growth rates of 50-60% [4][24] Market Dynamics - The competitive landscape in the Chinese minimally invasive surgical market has shifted, with major international players like Johnson & Johnson and Medtronic losing market share due to high costs associated with bidding [7][8] - The implementation of centralized procurement policies has led to significant price reductions for products like disposable puncture devices, creating substantial opportunities for domestic companies like Kangji [7][8] - The market for surgical robots in China is currently dominated by the Da Vinci system, but domestic brands are gradually gaining traction [9] Risks and Challenges - Potential risks include the impact of centralized procurement and DRG (Diagnosis-Related Group) policies on hospital surgery volumes and physician engagement [26] - Intense competition in the consumables market necessitates effective promotion by distributors, and uncertainties exist regarding overseas market expansion, including tariff risks in Europe [26] - New products, particularly energy sources and devices, may face regulatory and market entry challenges [26] Conclusion - Kangji Medical is positioned well within the rapidly growing Chinese minimally invasive surgical market, with a strong focus on innovation and market expansion. However, the company must navigate various risks associated with market competition and regulatory environments to sustain its growth trajectory.

2025 春季 CMEF 正如火如荼地进行，手术机器人再次成为焦点。 国产手术机器人如何破局？除了技术，还能拼什么？有哪些厂商真正在构建"可合作、可落 地"的平台？ 带着这些问题，思宇 MedTech 记者走进了佗道医疗展台，观察这家新锐企业如何 通过一场 "生态发布会" 与一场 "全国招商大会" ，全面展现其"双轮驱动"战 略——不只是"产品组合拳"，更是"产业组织力"的实战演练。 佗道医疗的战略目标并非做一个 "全能大厂"，而是成为一个多方共赢的平台型企业。这意味着不仅产品日益丰富，还 积极搭建一个清晰框架、成熟机制的开放型 生态系统 。无论是特色耗材厂商、经销商，还是希望接入手术机器人市场的合作伙伴，都能在这个平台找到适配入口。 下面附上一些细节，要了解更详细的内容，还请来展台（ 5.1 馆 K48 号位 ）。 这一战略的核心不仅是技术接口的对接，更是在产业结构层面推动 从 "封闭集成"向"横向共创" 的转型。 佗道希望通过"平台赋能"合作，推动机器人专用耗材与 传统医疗 器械的深度融合，共享行业结构性红利。 正 如程敏董事长 会上 所言： "生态的关键，不是产品多，而是系统通。" 在一个以协同创新驱动 ...